Nuwellis (NUWE) stock is surging in premarket trading on January 27, 2026, primarily driven by the announcement of a new U.S. patent for advanced safety mechanisms in its blood filtration systems. The patent strengthens their intellectual property portfolio for the Aquadex system, indicating potential for increased adoption in pediatric and fluid management care